Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease

Clinical trial NCT02148718 · COMPLETED

Trial details

NCT number: NCT02148718
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Moderate to Severe Crohn's Disease

Start date: 2014-06-01
Primary completion: 2016-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.